Clinical Trial Update: A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial is planned to assess the safety, tolerability, and pharmacokinetics of the investigational therapy EDK060 in adults with Charcot-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1a

Drugs mentioned

• EDK060

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Charcot-Marie-Tooth Disease, Type 1A | Phase 1 | Status: RECRUITING